SV

Street Verdict

Analyst Scorecard

A record of what Rahul Chadha said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on the healthcare sector, specifically hospitals, traditional pharma, and CDMOs. Hospitals have a secular demand story driven by increasing chronic diseases and improved willingness to pay, including through insurance. Traditional pharma is benefiting from stable generic drug pricing in the US, and potential new triggers like GLP-1 opportunities in markets like Canada over the next 2-3 years. Valuations and avoiding one-off opportunities are key considerations.”
Nifty Healthcare IndexBullishCalled 08 Jan 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee Rahul Chadha’s full track record